Kosunen O, Soininen H, Paljärvi L, Heinonen O, Talasniemi S, Riekkinen P J
Department of Neurology, University of Kuopio, Finland.
Acta Neuropathol. 1996;91(2):185-93. doi: 10.1007/s004010050412.
This prospective study focused on the accuracy of diagnosis of Alzheimer's disease (AD). We recruited 100 dementia patients and 20 controls who underwent a systematic evaluation. The clinical diagnosis of probable AD or possible AD according to the NINCDS-ADRDA criteria was assigned in 69% of the patients, 21% had vascular dementia (VaD) (DSM-III-R) and 8% had mixed AD-VaD; only 2 patients (2%) had the Lewy body variant of AD (AD-LB). During a 3-year period 57 patients died, 53 of them (93%) being autopsied. Neuropathological examination according to the CERAD criteria showed definite AD in 27 out of 28 (96%) patients diagnosed as probable AD. In the possible AD group, the diagnostic accuracy was also high, 86% showed at least some degree of AD pathological alterations. The neocortical senile plaque scores correlated significantly with tangle scores in patients with AD pathology, and there was a significant negative correlation between age of onset and neocortical tangle scores. The concordance between the clinical diagnosis and pathological findings was clearly lower in VaD than in AD. In the clinical VaD group, 8 of 10 patients had at least some degree of AD changes together with vascular changes and only 2 of 10 patients had pure VaD. This study confirms the high accuracy of the NINCDS-ADRDA criteria for diagnosing AD. In contrast, uncertainty in the clinical diagnosis of VaD should be taken into account, for example, in drug trials with VaD patients.
这项前瞻性研究聚焦于阿尔茨海默病(AD)的诊断准确性。我们招募了100名痴呆患者和20名对照者,他们均接受了系统评估。根据NINCDS - ADRDA标准,69%的患者被临床诊断为可能AD或疑似AD,21%患有血管性痴呆(VaD)(DSM - III - R),8%患有AD - VaD混合型;仅有2名患者(2%)患有路易体变异型AD(AD - LB)。在3年期间,57名患者死亡,其中53名(93%)接受了尸检。根据CERAD标准进行的神经病理学检查显示,在被诊断为可能AD的28名患者中,有27名(96%)确诊为AD。在疑似AD组中,诊断准确性也很高,86%的患者至少有一定程度的AD病理改变。在患有AD病理改变的患者中,新皮质老年斑评分与缠结评分显著相关,且发病年龄与新皮质缠结评分之间存在显著负相关。VaD患者临床诊断与病理结果之间的一致性明显低于AD患者。在临床VaD组中,10名患者中有8名至少有一定程度的AD改变以及血管改变,只有10名患者中的2名患有单纯VaD。本研究证实了NINCDS - ADRDA标准在诊断AD方面具有很高的准确性。相比之下,例如在针对VaD患者的药物试验中,应考虑到VaD临床诊断的不确定性。